Paul M. Titchenell, Ph.D.
Associate Professor of Physiology
Director, Social Media and Scientific Outreach, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania
Co-Director, Academic Enrichment Program, Diabetes Research Center, University of Pennsylvania
Faculty Director, Trainee Recruitment , Inclusivity, Diversity, Equity, and Learner (IDEAL) Research, University of Pennsylvania
Co-Director, Summer Undergraduate Internship Program (SUIP), Inclusivity, Diversity, Equity, and Learner (IDEAL) Research, University of Pennsylvania
Director, Rodent Metabolic Phenotyping Core, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania
Department: Physiology
Graduate Group Affiliations
Contact information
Institute for Diabetes, Obesity, and Metabolism
Smilow Center for Translational Research
3400 Civic Center Blvd, Building 421
Room: 12-104
Philadelphia, PA 19104
Smilow Center for Translational Research
3400 Civic Center Blvd, Building 421
Room: 12-104
Philadelphia, PA 19104
Office: 215-573-1872
Lab: 215-573-1875
Lab: 215-573-1875
Email:
ptitc@pennmedicine.upenn.edu
ptitc@pennmedicine.upenn.edu
Publications
Links
Search PubMed for articles
Physiology Faculty Page
Institute for Diabetes, Obesity, and Metabolism
Titchenell Lab Website
Search PubMed for articles
Physiology Faculty Page
Institute for Diabetes, Obesity, and Metabolism
Titchenell Lab Website
Education:
B.S. (Biochemistry and Molecular Biology)
Dickinson College, 2008.
Ph.D. (Physiology)
Pennsylvania State University, 2013.
Permanent linkB.S. (Biochemistry and Molecular Biology)
Dickinson College, 2008.
Ph.D. (Physiology)
Pennsylvania State University, 2013.
Description of Research Expertise
Research Interests:Molecular mechanisms of insulin signaling, insulin resistance, obesity, diabetes and metabolism
Keywords:
metabolism, insulin, diabetes, obesity, AKT, mTORC1
Research Details:
The Titchenell lab studies the molecular control of metabolism with the goal of identifying new therapeutic targets and approaches to treat metabolic diseases such as diabetes, obesity and cancer. Specifically, the Titchenell laboratory focuses on hormone and nutrient signaling with a particular interest in glucose, fat and protein metabolism. The lab employs a host of cutting-edge technologies in biochemistry, molecular biology and organismal physiology to address fundamental questions in physiology and disease. In addition to his own research program, Dr. Titchenell serves as Director of the Rodent Metabolic Phenotyping Core (RMPC) at Penn. The RMPC's mission is to provide state-of-the-art technologies, expertise and services for diabetes, obesity and metabolism researchers. Please visit the RMPC website to learn more about the services that are available: https://www.med.upenn.edu/idom/drc/cores/rodent.html.
Current Lab personnel:
Matthew Gavin (Research Specialist/Lab manager)
Matthew Harris Ph.D. (Postdoctoral Researcher)
Jaclyn Welles Ph.D. (Postdoctoral Researcher)
Dominic Santoleri (PhD student, BMB graduate group)
Anna Garcia Whitlock M.D/Ph.D. (Resident/Fellow)
Megan Stefkovich,(PhD student, CAMB graduate group)
Libby Nunn (PhD student, CAMB graduate group)
Talia Coopersmith (Penn undergraduate-PURM)
Olivia Ong (Penn undergraduate)
Selected Publications
Perry RJ, Camporez JG, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, Ruan HB, Yang X, Caprio S, Kaech SM, Sul HS, Birnbaum MJ, Davis RJ, Cline GW, Petersen KF, Shulman GI.: Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160: 745-758, Feb 2015.Titchenell PM, Quinn WJ, Lu M, Chu Q, Lu W, Li C, Chen H, Monks BR, Chen J, Rabinowitz JD, Birnbaum MJ.: Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab 23: 1154-1166, Jun 2016.
Quinn WJ 3rd, Wan M, Shewale SV, Gelfer R, Rader DJ, Birnbaum MJ, Titchenell PM.: mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. J Clin Invest 127: 4207-4215, Nov 2017.
Jaiswal N, Gavin MG, Quinn WJ 3rd, Luongo TS, Gelfer RG, Baur JA, Titchenell PM.: The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis. Mol Metab 28: 1-13, Oct 2019.
Sostre-Colón J, Uehara K, Garcia Whitlock AE, Gavin MJ, Ishibashi J, Potthoff MJ, Seale P, Titchenell PM.: Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms. Cell Rep 35: 109128, May 2021.
Jaiswal N, Gavin M, Loro E, Sostre-Colón J, Roberson PA, Uehara K, Rivera-Fuentes N, Neinast M, Arany Z, Kimball SR, Khurana TS, Titchenell PM.: AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology. J Cachexia Sarcopenia Muscle 13(1495-514), Feb 2022.
Uehara K, Santoleri D, Garcia Whitlock A, Titchenell PM: Insulin Regulation of Hepatic Lipid Homeostasis. Comprehensive Physiology In press: 4785-4809, Jun 2023.
Uehara K, Lee WD, Stefkovich M, Biswas D, Santoleri D, Garcia Whitlock AE, Quinn Iii WJ, Coopersmith TN, Creasy KT, Rader DJ, Sakamoto K, Rabinowitz JD, Titchenell PM.: mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b. J Clin Invest Jan 2024.
Nunn E, Jaiswal N, Gavin M, Uehara K, Stefkovich M, Drareni K, Calhoun R, Lee M, Holman CD, Baur JA, Seale P, Titchenell PM.: Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Mol Metab 80: 101880, Jan 2024.